Rocket Pharmaceuticals Warrant
RCKTW
12 hedge funds and large institutions have $165K invested in Rocket Pharmaceuticals Warrant in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
15% less capital invested
Capital invested by funds: $195K → $165K (-$30K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$611 |
| 2 |
TSS
Two Sigma Securities
New York
|
+$538 |
| 3 |
CS
Clear Street
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$10.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.72K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$50 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$42 |
RCKTW Hedge Fund Activity: Q4 2025 in Review
12 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q4 2025, worth a combined $165K — down 15% from $195K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RCKTW positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $611. The largest seller was Walleye Capital, cutting an estimated $10.1K.
- 12 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q4 2025, up from 11 in Q3 2025.
- Funds reported $165K of Rocket Pharmaceuticals Warrant stock for Q4 2025, down 15% quarter-over-quarter.
- 3 funds opened new Rocket Pharmaceuticals Warrant positions in Q4 2025 and 2 closed out, a net change of +1 holder.
- The largest Rocket Pharmaceuticals Warrant buyer in Q4 2025 was Virtu Financial, an estimated $611 added.
- The largest Rocket Pharmaceuticals Warrant seller in Q4 2025 was Walleye Capital, an estimated $10.1K sold.
Based on aggregated 13F filings for Q4 2025.